Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flepp

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1985
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacinB Ledergerber, J D Bettex, B Joos, et al.
Journal of Perinatal Medicine|January 1, 1995
Pregnancy, immunosuppression and reactivation of latent toxoplasmosisK Biedermann, M Flepp, W Fierz, et al.
AIDS (London, England)|September 1, 1996
Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reactionJ Schüpbach, M Flepp, D Pontelli, et al.
The Clinical Investigator|October 1, 1992
Q fever endocarditis: diagnostic approaches and monitoring of therapeutic effectsO Péter, M Flepp, G Bestetti, et al.
Journal of Medical Virology|September 6, 2001
Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNAJ Schüpbach, J Böni, M Flepp, et al.
Praxis|April 23, 2003
[25-year-old therapy naive patient with 3 class resistant HIV infection]B Hasse, Y Hummel, J Böni, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in womenF Garlando, S Rietiker, M G Täuber, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1985
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urineB Joos, B Ledergerber, M Flepp, et al.
International Journal of Antimicrobial Agents|December 19, 2000
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failureJ Schüpbach, Z Tomasik, D Nadal, et al.
AIDS Care|November 25, 2000
A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, SwitzerlandB Somaini, J Wang, M Perozo, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|March 1, 1985
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacinB Ledergerber, J D Bettex, B Joos, et al.
Journal of Perinatal Medicine|January 1, 1995
Pregnancy, immunosuppression and reactivation of latent toxoplasmosisK Biedermann, M Flepp, W Fierz, et al.
AIDS (London, England)|September 1, 1996
Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reactionJ Schüpbach, M Flepp, D Pontelli, et al.
The Clinical Investigator|October 1, 1992
Q fever endocarditis: diagnostic approaches and monitoring of therapeutic effectsO Péter, M Flepp, G Bestetti, et al.
Journal of Medical Virology|September 6, 2001
Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNAJ Schüpbach, J Böni, M Flepp, et al.
Praxis|April 23, 2003
[25-year-old therapy naive patient with 3 class resistant HIV infection]B Hasse, Y Hummel, J Böni, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in womenF Garlando, S Rietiker, M G Täuber, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1985
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urineB Joos, B Ledergerber, M Flepp, et al.
International Journal of Antimicrobial Agents|December 19, 2000
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failureJ Schüpbach, Z Tomasik, D Nadal, et al.
AIDS Care|November 25, 2000
A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, SwitzerlandB Somaini, J Wang, M Perozo, et al.
Pageof 7